M1 Kliniken AG, together with its subsidiaries, operates medical centers for aesthetic and plastic surgery in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, and Australia. The company operates in two segments, Beauty and Trade. It develops and markets pharmaceutical, medical, and medical technology products for aesthetic medicine and cosmetic dermatology, as well as trades in pharmaceutical, biosimilars, and other medical products and devices in the areas of oncology, HIV, rheumatism, neurology, cardiovascular diseases, and narcotics. The company also engages in the acquisition, management, and sale of real estate, primarily in the health care sector. It offers its products to doctors, pharmacies, and wholesalers under the M1 Select brand. The company operates a network of outpatient specialist centers; and a specialized surgical clinic center, as well as 46 specialist centers under the M1 Med Beauty brand. M1 Kliniken AG was founded in 2007 and is based in Berlin, Germany. M1 Kliniken AG operates as a subsidiary of MPH Health Care AG.
P/E ratio for M1 Kliniken AG (M12.DE)
P/E ratio as of 2023: 20.85
According to M1 Kliniken AG's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 20.85. At the end of 2022 the company had a P/E ratio of 38.43.
P/E ratio history for M1 Kliniken AG from 2013 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | 20.85 |
| 2022 | 38.43 |
| 2021 | 15.65 |
| 2020 | 25.17 |
| 2019 | 25.72 |
| 2018 | 37.12 |
| 2017 | 34.83 |
| 2016 | 31.60 |
| 2015 | 12.10 |
| 2014 | 16.36 |
| 2013 | 688.14 |